Australia PBS Seeks To Lower High Cost Of BMS Melanoma Drug
This article was originally published in PharmAsia News
Executive Summary
Australia's Pharmaceutical Benefits Scheme is attempting to negotiate with Bristol Myers Squibb to lower the price of its Yervoy (ipilimumab) so melanoma patients can afford it.